Workshop Programme. 10 May 2017

Size: px
Start display at page:

Download "Workshop Programme. 10 May 2017"

Transcription

1 Workshop Programme 10 May 2017 Kindly sponsored by Abbott Cerus Corporation DiaSorin S.p.A. GFE Blut Grifols Macopharma Roche Diagnostics Terumo BCT - Page 1

2 Day I - Tuesday 16 May hrs SESSION 1 OPENING SESSION Chair: Dr P. Strengers Welcome and Introduction Dr P. Strengers, IPFA (the Netherlands) (5 mins) Formal Opening Croatia Ministry of Health Official (15 mins) Transfusion service in Croatia Dr I. Jukic, Croatian Institute of Transfusion Medicine (Croatia) (20 mins) Key-Note: Large data, omics of donors/recipients, personalized medicine Dr C. Erikstrup, Aarhus University Hospital (Denmark) (30 mins) hrs COFFEE BREAK hrs SESSION 2 HEV SCREENING Chair: Prof. Dr H. Zaaijer Ireland donor screening results Dr J. O Riordan, Irish Blood Transfusion Service (Ireland) (20 mins) The introduction of universal HEV Screening Prof. R. Tedder, Public Health England (United Kingdom) (20 mins) Strategies for HEV donor screening: no screening/universal/selective Prof. P. Tiberghien, Etablissement Français du Sang (France) (20 mins) Panel discussion hrs LUNCH hrs SESSION 3 MANAGING DONOR DEFERRAL Chair: Prof. Dr E. Seifried Selecting the right donors still a challenge Dr R. Offergeld, Robert Koch Institute (Germany) (20 mins) US perspective/experience on modeling studies for donor deferral Dr H. Yang, U.S. Food and Drug Administration (USA) (20 mins) How to design intranational deferral (Malaria in Greece etc.) - Prof. C. Politis, Greece (20 mins) Roche Diagnostics Terumo BCT - Page 2

3 hrs COFFEE BREAK hrs SESSION 4 UPDATE SESSION Chair: Dr F. Rossi Zika screening in US Dr D. Leiby, U.S. Food and Drug Administration (USA) (20 mins) UK vcjd update: met/val vcjd patient and Appendix-III study Prof. R.G. Will, Western General Hospital (United Kingdom) (30 mins) Testing for Babesia and/or Malaria Dr S.L. Stramer, American Red Cross (USA) (20 mins) An unusual plasma pool tested at NIBSC Dr R. Anderson, National Institute for Biological Standards and Control (United Kingdom) (15 mins) hrs END OF DAY I hrs (DEPARTURE FOR) DINNER Day II - Wednesday 17 May hrs SESSION 5 MANUFACTURERS SESSION Chair: Dr N. Lelie Abbott (20 mins): Designing purpose-built assays for blood and plasma screening: Internal and external evaluation of the Abbott Alinity s assays Mr M Paradowski and Dr I. Mihaljevic (20 mins) Cerus Corporation: Completing the Picture Attaining a Safe, Sustainable Blood Supply with Pathogen Inactivation - Dr R. Benjamin (20 mins) GFE Blut: New Developments from GFE Blut - Prof. Dr K. Roth (Germany) (20 mins) Grifols Research & Development: Update on Tests in Development to Address Infectious Disease Threats to Blood Safety Dr J. Linnen (USA) (20 mins) Roche: "cobas 6800/8800 Systems: Driving Blood Safety with Rapid Response to Parasitic Diseases" Mr T. Hardiman (20 mins) Roche Diagnostics Terumo BCT - Page 3

4 hrs COFFEE BREAK hrs SESSION 6 PATHOGEN INACTIVATION Chair / Moderator: Dr C. Schaerer Efficacy of Pathogen Inactivation Prof. Dr H. Zaaijer, Sanquin BOI (the Netherlands) (20 mins) Pathogen Inactivation and function of platelets and red cells Dr D. Devine, Canadian Blood Services (Canada) (20 mins) Industry views: - Cerus: Dr R. Benjamin (3 mins) - Macopharma: Dr I. Alvarez (3 mins) - Terumo BCT: Dr M. Cardoso (3 mins) Panel discussion (30 mins) moderator: Dr C. Schaerer hrs LUNCH hrs SESSION 7 IMPACT OF REGULATORY REQUIREMENTS - NAT SCREENING Chair / Moderator: Dr D. Leiby Global approach emergency quality assessment of IVDs Ms R. Meurant, World Health Organisation (Switzerland) (20 mins) PI + NAT + serology: Eliminating old tests? An integrated approach Prof. Dr E. Seifried, German Red Cross Blood Transfusion Service (Germany) (20 mins) Industry views: - GFE Blut: Prof. Dr K. Roth (3 mins) - Grifols: Dr J. Holmberg (3 mins) - Roche: Mr T. Hardiman (3 mins) Panel discussion (30 mins) moderator: Dr D. Leiby Roche Diagnostics Terumo BCT - Page 4

5 15.30 hrs SESSION 8 ADVANCES IN HIV CURE RESEARCH AND IMPACT OF EARLY THERAPY ON HIV DIAGNOSIS AND DONOR SCREENING Chair: Dr T. van de Laar Keynote: Progress Towards and HIV Cure Prof. S. Deeks, University of California (USA) (30 mins) Very early antiretroviral treatment (ART) of South African blood donors and detection of ART drugs in NAT-negative/antibody positive donors Ms M. Vermeulen, South African National Blood Service (South Africa) (25 mins) Keynote: Impact of pre-exposure prophylaxis and early treatment on performance of assays for HIV diagnosis and donor screening Dr M.P. Busch, Blood Systems Research Institute (USA) (25 mins) hrs CLOSURE hrs FAREWELL DRINKS Roche Diagnostics Terumo BCT - Page 5

IPFA/PEI 20th International Workshop on. Surveillance and Screening of Blood Borne Pathogens

IPFA/PEI 20th International Workshop on. Surveillance and Screening of Blood Borne Pathogens xler 20 mins. IPFA/PEI 20th International Workshop on Surveillance and Screening of Blood Borne Pathogens HELSINKI AT standardization ONS t) 30 mins. In collaboration with the Finnish Red Cross Blood Service

More information

Symposium Program. 28 August Kindly sponsored by Abbott Fresenius Kabi USA, LLC QualTex Laboratories Roche Terumo BCT - Page 1

Symposium Program. 28 August Kindly sponsored by Abbott Fresenius Kabi USA, LLC QualTex Laboratories Roche Terumo BCT - Page 1 Symposium Program 28 August 2017 Kindly sponsored by Abbott Fresenius Kabi USA, LLC QualTex Laboratories Roche Terumo BCT - Page 1 Day I Monday 11 September 2017 09:00 hrs Session 1: OPENING SESSION Chairperson:

More information

Symposium Program. 26 July Kindly sponsored by Abbott Fresenius Kabi USA, LLC Terumo BCT QualTex Laboratories - Page 1

Symposium Program. 26 July Kindly sponsored by Abbott Fresenius Kabi USA, LLC Terumo BCT QualTex Laboratories - Page 1 Symposium Program 26 July 2017 Kindly sponsored by Abbott Fresenius Kabi USA, LLC Terumo BCT QualTex Laboratories - Page 1 Theme: Exploring the potential for donors and Blood Centers to increase their

More information

Symposium on Plasma Supply Management January Draft Programme (subject to change) Tuesday, 29 January 2019

Symposium on Plasma Supply Management January Draft Programme (subject to change) Tuesday, 29 January 2019 Symposium on Plasma Supply Management 29-30 January 2019 Location: EDQM premises, Strasbourg, France Working language: English 08:00-09:00 Registration Draft Programme (subject to change) Tuesday, 29 January

More information

Symposium on Plasma Supply Management January Tuesday, 29 January 2019

Symposium on Plasma Supply Management January Tuesday, 29 January 2019 Symposium on Plasma Supply Management 29-30 January 2019 Location: EDQM premises, Strasbourg, France Working language: English 08:00-09:00 Registration Draft Programme (subject to change) Tuesday, 29 January

More information

The Biological Impact of Pathogen Inactivation on Blood Product Quality

The Biological Impact of Pathogen Inactivation on Blood Product Quality PERMISSON TO USE: Please note that, by making their presentations available on-line, primary authors have agreed to share their presentations. However, should you want to use some of the data or slides

More information

Meeting between International Plasma Fractionators Association (IPFA) and DG SANTE B4. 17 April Summary Minutes

Meeting between International Plasma Fractionators Association (IPFA) and DG SANTE B4. 17 April Summary Minutes Ref. Ares(2018)3697046-11/07/2018 EUROPEAN COMMISSION DIRECTORATE-GENERAL FOR HEALTH AND FOOD SAFETY Directorate B - Health systems, medical products and innovation B4 Medical products: quality, safety

More information

Supplementary Online Content

Supplementary Online Content Supplementary Online Content Garban F, Guyard A, Labussière H, et al; Evaluation of the Efficacy of Platelets Treated With Pathogen Reduction Process (EFFIPAP) Study Group. Comparison of the hemostatic

More information

Asia Pacific Economies Drive Quality

Asia Pacific Economies Drive Quality Asia Pacific Economies Drive Quality Industry s Response Jerry A Holmberg, Ph.D. Director, Scientific Business Development March 3, 2017 GRP No. DL/TMP/0217/0007 Agenda What is APEC? Why is blood sustainability

More information

Re: Docket No. FDA 2018-D-2478, Recommendations for Reducing the Risk of Transfusion- Transmitted Babesiosis draft guidance, July 27, 2018

Re: Docket No. FDA 2018-D-2478, Recommendations for Reducing the Risk of Transfusion- Transmitted Babesiosis draft guidance, July 27, 2018 September 28, 2018 Division of Dockets Management (HFA 305) Food and Drug Administration 5630 Fishers Lane, Rm. 1061 Rockville, MD 20852 Submitted via http://www.regulations.gov Re: Docket No. FDA 2018-D-2478,

More information

Cell Therapy Liaison Meeting, January 27, 2006

Cell Therapy Liaison Meeting, January 27, 2006 Cell Therapy Liaison Meeting, January 27, 2006 Bethesda, MD, Summary Attendees were welcomed by Stephen J. Noga, MD, PhD, ISCT FDA Liaison and the meeting was called to order at 8:15am. HIV and HCV NAT

More information

ESCV. Scientific Programme ATHENΣ 2018 CLINICAL VIROLOGY EUROPEAN SOCIETY FOR SEPTEMBER - ZAPPEION MEGARON.

ESCV. Scientific Programme ATHENΣ 2018 CLINICAL VIROLOGY EUROPEAN SOCIETY FOR SEPTEMBER - ZAPPEION MEGARON. Organized by 21 23-26 SEPTEMBER - ZAPPEION MEGARON www.escv2018.com Scientific Programme Congress Secretariat www.free-spirit.gr 23-26 SEPTEMBER - ZAPPEION MEGARON 21 Scientific Programme Sunday 23 rd

More information

Pathogen Inactivation and Blood Safety in the US. Richard Benjamin, MD PhD Chief Medical Officer Washington, D.C.

Pathogen Inactivation and Blood Safety in the US. Richard Benjamin, MD PhD Chief Medical Officer Washington, D.C. Pathogen Inactivation and Blood Safety in the US Richard Benjamin, MD PhD Chief Medical Officer Washington, D.C. Conflict of Interest The American Red Cross is participating in a clinical trial of the

More information

Session 13: Prequalification Within the Context of Global Fund Procurements

Session 13: Prequalification Within the Context of Global Fund Procurements Session 13: Prequalification Within the Context of Global Fund Procurements Established in 2002 Global Fund Attracts and disburses additional resources to prevent and treat AIDS, tuberculosis (TB), and

More information

European Conference on SHARING BEST PRACTICES: QUALITY RISK MANAGEMENT, CHANGE CONTROL, VALIDATION AND QUALIFICATION. in Blood Establishments

European Conference on SHARING BEST PRACTICES: QUALITY RISK MANAGEMENT, CHANGE CONTROL, VALIDATION AND QUALIFICATION. in Blood Establishments European Conference on SHARING BEST PRACTICES: QUALITY RISK MANAGEMENT, CHANGE CONTROL, VALIDATION AND QUALIFICATION in Blood Establishments 17-19 October 2017 European Directorate for the Quality of Medicines

More information

THE EUROPEAN BLOOD BANKING MARKET: France, Germany, Italy, Spain, UK Emerging Opportunities and Business Expansion Strategies.

THE EUROPEAN BLOOD BANKING MARKET: France, Germany, Italy, Spain, UK Emerging Opportunities and Business Expansion Strategies. I. Introduction THE EUROPEAN BLOOD BANKING MARKET: France, Germany, Italy, Spain, UK Emerging Opportunities and Business Expansion Strategies Table of Contents II. Worldwide Technology and Market Overview

More information

70% not diagnosed, 75% not treated Many die in childhood or grow-up severely disabled

70% not diagnosed, 75% not treated Many die in childhood or grow-up severely disabled Economic Reality and the Development of Haemophilia Care Brian O Mahony, CEO Irish Haemophilia Society Esfahan, Iran April 2009 1 Haemophilia Care Globally 70% not diagnosed, 75% not treated Many die in

More information

Plasma for Fractionation

Plasma for Fractionation www.pei.de Plasma for Fractionation Regulatory & Quality Standards in the EU Dr. Sabine Wegehaupt Inspection Services for Biological Medicinal Products IPFA Workshop Stellenbosch December 01-02, 2015 Plasma

More information

The Role of Research in Supporting Regulation of Biologicals: Building Bridges from Biomedical Discovery to Innovative Products

The Role of Research in Supporting Regulation of Biologicals: Building Bridges from Biomedical Discovery to Innovative Products The Role of Research in Supporting Regulation of Biologicals: Building Bridges from Biomedical Discovery to Innovative Products Jay S. Epstein, M.D. CBER, FDA Biologicals are Complex Products Critical

More information

Plasma fractionation: Technical and organisational points to consider

Plasma fractionation: Technical and organisational points to consider IPFA workshop Yogyakarta, Indonesia March 2 nd -3 rd, 2017 醫學工程學院 College of Biomedical Engineering Plasma fractionation: Technical and organisational points to consider Thierry Burnouf, Prof., PhD College

More information

Quotient Limited. Jefferies Healthcare Conference. June 2017

Quotient Limited. Jefferies Healthcare Conference. June 2017 Quotient Limited Jefferies Healthcare Conference June 2017 Safe Harbor Statement This presentation contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and

More information

Biomarkers and Patient s Access to Personalized Oncology Drugs in Europe

Biomarkers and Patient s Access to Personalized Oncology Drugs in Europe CDDF Cancer Drug Development Forum CDDF MULTI - STAKEHOLDER WORKSHOP Biomarkers and Patient s Access to Personalized Oncology Drugs in Europe Brussels, Belgium 24-25 September 2018 PROGRAMME PROGRAMME

More information

IAHA International Conference on Organic Animal Husbandry organized at NCOF, Ghaziabad (India) on 6 8 Nov, 2017

IAHA International Conference on Organic Animal Husbandry organized at NCOF, Ghaziabad (India) on 6 8 Nov, 2017 IAHA International Conference on Organic Animal Husbandry organized at NCOF, Ghaziabad (India) on 6 8 Nov, 2017 The International Conference on the ROLE OF LIVESTOCK IN SUSTAINABLE AGRICULTURE the Pre

More information

The Worldwide Alpha-1 Antitrypsin Market. Present Situation and Future Prospects

The Worldwide Alpha-1 Antitrypsin Market. Present Situation and Future Prospects The Worldwide Alpha-1 Antitrypsin Market Present Situation and Future Prospects 2005-2015 TABLE OF CONTENTS November 2005 TABLE OF CONTENTS Executive Summary 15 Introduction. 33 Description, Background

More information

Virus Safety in Plasma- Derived Therapeutics: A Merck Perspective. IPFA Yogyakarta, March Louis Wong

Virus Safety in Plasma- Derived Therapeutics: A Merck Perspective. IPFA Yogyakarta, March Louis Wong Virus Safety in Plasma- Derived Therapeutics: A Merck Perspective IPFA Yogyakarta, March 2017 Louis Wong Associate director, Plasma Initiative, Asia-Pacific Content Regulatory Expectations for Plasma-Derived

More information

FIRST WEEK PROGRAMME AN INTRODUCTION TO SOLID OXIDE FUEL CELL TECHNOLOGY

FIRST WEEK PROGRAMME AN INTRODUCTION TO SOLID OXIDE FUEL CELL TECHNOLOGY PROGRAMME FIRST WEEK Sunday, 21 st August 2011 19:00 Welcome, Early Registration, Dinner Monday, 22 nd August 2011 08:30-09:00 Welcome 09:00-11:00 Introduction to Fuel Cells: - Status and applications

More information

Impact of WHO Guidelines on GMP for Blood Establishments

Impact of WHO Guidelines on GMP for Blood Establishments Impact of WHO Guidelines on GMP for Blood Establishments Christian Schärer, Ph.D. Swissmedic, Swiss Agency for Therapeutic Products, Head Inspectorate International Conference of Drug Regulatory Authorities

More information

Workshop Legal instruments for the effective protection and sustainable management of soils

Workshop Legal instruments for the effective protection and sustainable management of soils Workshop Legal instruments for the effective protection and sustainable management of soils Organized in cooperation between the German Environment Agency (UBA), the Konrad Adenauer Stiftung Climate Policy

More information

7 th Summer School on Infection Research

7 th Summer School on Infection Research 7 th Summer School on Infection Research Sunday, 27 May 2018 27 31 May 2018 Hotel Weißer Hirsch, Wernigerode 13:00-15:30 Registration & Check-In 15:30 Coffee - in front of room Brocken 16:00 Welcome H.

More information

Working Party of Senior Budget Officials

Working Party of Senior Budget Officials Unclassified GOV/PGC/SBO/A(2011)5 GOV/PGC/SBO/A(2011)5 Unclassified Organisation de Coopération et de Développement Économiques Organisation for Economic Co-operation and Development 23-Jun-2011 English

More information

HANDLING AND SHIPPING OF INFECTIOUS SUBSTANCES FOR CLINICAL TRIALS

HANDLING AND SHIPPING OF INFECTIOUS SUBSTANCES FOR CLINICAL TRIALS STANDARD OPERATING PROCEDURE HANDLING AND SHIPPING OF INFECTIOUS SUBSTANCES FOR CLINICAL TRIALS Standard Operating Procedure Western Health SOP reference 012 Version: 2.0 dated December 2015 Effective

More information

Pre- ICDRA Exhibition Guide

Pre- ICDRA Exhibition Guide Pre- ICDRA Exhibition Guide Invitation to Exhibit at PRE- ICDRA 3-4 September 2018 The HPRA is honoured to have been selected by the World Health Organization (WHO) to host delegates from each of the WHO

More information

Invitation to the two-yearly RTDE Conference, October 2017, Wemmel/Brussels.

Invitation to the two-yearly RTDE Conference, October 2017, Wemmel/Brussels. Invitation to the two-yearly RTDE Conference, 11-12 October 2017, Wemmel/Brussels. It has taken a lot of time in negotiating with our MEP representatives for our presentation in the European Parliament

More information

This document is a preview generated by EVS

This document is a preview generated by EVS TECHNICAL SPECIFICATION SPÉCIFICATION TECHNIQUE TECHNISCHE SPEZIFIKATION CEN/TS 16835-3 October 2015 ICS 11.100.30 English Version Molecular in vitro diagnostic examinations - Specifications for pre-examination

More information

Programme. Ethics in Regulatory Affairs for Pharmaceutical Products: dilemmas in decision-makings. Preliminary version ( )

Programme. Ethics in Regulatory Affairs for Pharmaceutical Products: dilemmas in decision-makings. Preliminary version ( ) Location: MAERSK TOWER (Room 13.1.63 - OBS! 4 TH of October Room 7.15.122) Programme Ethics in Regulatory Affairs for Pharmaceutical Products: dilemmas in decision-makings 3 rd 6 th October 2017 Preliminary

More information

Macopharma Blood Safety Symposium. THERAFLEX Pathogen Reduction Technologies

Macopharma Blood Safety Symposium. THERAFLEX Pathogen Reduction Technologies Macopharma Blood Safety Symposium THERAFLEX Pathogen Reduction Technologies A regional haemovigilance retrospective study of four types of therapeutic plasma in a ten-year period survey in France (EFS

More information

PROSPECTUS. Regional Workshop 6: Project Output Dissemination and Terminal Workshop 7-9 April 2015, Hotel Hollywood, Sarajevo Bosnia and Herzegovina

PROSPECTUS. Regional Workshop 6: Project Output Dissemination and Terminal Workshop 7-9 April 2015, Hotel Hollywood, Sarajevo Bosnia and Herzegovina 1 P a g e PROSPECTUS FAO TCP/RER/3402 Assistance to Western Balkan Countries for Improving Compliance to International Standards on Aquatic Animal Health Regional Workshop 6: Project Output Dissemination

More information

These slides and the data they contain are the sole property of the author(s) of the slide set.

These slides and the data they contain are the sole property of the author(s) of the slide set. These slides and the data they contain are the sole property of the author(s) of the slide set. Reproduction or distribution of the content of the slides or the data they contain requires the prior, specific

More information

Track and trace for access to safe medicines

Track and trace for access to safe medicines Track and trace for access to safe medicines Every day millions of patients across the world depend on safe medication. Unfortunately, presence of falsified medication is a huge threat to patient safety,

More information

Provisional programme

Provisional programme Provisional programme April, 2018 ISNH 2018 - September 2-6, 2018 - Clermont-Ferrand, France https://symposium.inra.fr/isnh2018 To become a sponsor, please contact: Nota bene: Oral offered papers & short

More information

WP Inspection Competence of Authorities

WP Inspection Competence of Authorities WP Inspection Competence of Authorities Eva G. Friberg (chair) and Steve Ebdon-Jackson 1 Action Plan Tasks: Survey on clinical competence 2012 Clinical training courses for Inspectors in UK 2014 HERCA

More information

13 15 SEPTEMBER 2017 SERVING LABORATORY MANAGEMENT & DIOGNOSTIC NETWORKS GLOBALLY BARCELONA CONGRESS CENTRE, BARCELONA, SPAIN

13 15 SEPTEMBER 2017 SERVING LABORATORY MANAGEMENT & DIOGNOSTIC NETWORKS GLOBALLY BARCELONA CONGRESS CENTRE, BARCELONA, SPAIN 13 15 SEPTEMBER 2017 BARCELONA CONGRESS CENTRE, BARCELONA, SPAIN SERVING LABORATORY MANAGEMENT & DIOGNOSTIC NETWORKS GLOBALLY www.medlabeurope.com medlabeurope@informa.com +34 518890041 INTRODUCTION It

More information

Monitoring the analytical sensitivity of Procleix reagent batches using ViraQ HEV Check controls and Trend controls

Monitoring the analytical sensitivity of Procleix reagent batches using ViraQ HEV Check controls and Trend controls Monitoring the analytical sensitivity of Procleix reagent batches using ViraQ HEV Check controls and Trend controls 25 years standardisation & quality control of NAT Fiona Boland, Irish Blood Transfusion

More information

Conference on Current and Innovative Approaches in Microbiological Food Safety Management. October 21-22, 2008

Conference on Current and Innovative Approaches in Microbiological Food Safety Management. October 21-22, 2008 Conference on Current and Innovative Approaches in Microbiological Food Safety Management October 21-22, 2008 Crystal Ballroom, Hotel Intercontinental The Grand Barakhamba Avenue, Connaught Place, New

More information

4 th International Advanced ICAS Training Course on "Blood Stem Cell Transplantation: State of the Arts, Methods, Perspectives" April 2007

4 th International Advanced ICAS Training Course on Blood Stem Cell Transplantation: State of the Arts, Methods, Perspectives April 2007 4 th International Advanced ICAS Training Course on "Blood Stem Cell Transplantation: State of the Arts, Methods, Perspectives" 16-19 April 2007 at the and Institute of Transfusion Medicine (Building of

More information

EU-OECD Programme on Promoting Investment in the Mediterranean REGIONAL SEMINAR. Institutional Reforms of Investment Promotion Agencies

EU-OECD Programme on Promoting Investment in the Mediterranean REGIONAL SEMINAR. Institutional Reforms of Investment Promotion Agencies EU-OECD Programme on Promoting Investment in the Mediterranean REGIONAL SEMINAR Institutional Reforms of Investment Promotion Agencies 30-31 January 2018 Rabat, Morocco Venue: Hotel Sofitel Jardin des

More information

EDCTP perspective on biopreparedness and related capacity development in Africa

EDCTP perspective on biopreparedness and related capacity development in Africa EDCTP perspective on biopreparedness and related capacity development in Africa Consultation workshop on Preparedness for emerging diseases Dr. Michael Makanga EDCTP Executive Director. 29 September 2016

More information

Report on Canada s Blood System. The Canadian Blood Services ***1/2

Report on Canada s Blood System. The Canadian Blood Services ***1/2 2003-2004 Report on Canada s Blood System 7 Years after The Commission of Inquiry on the Blood System in Canada Prepared by the Blood Safety Committee of the Canadian Hemophilia Society January 31, 2005

More information

EIP-AGRI Workshop Tools for environmental farm performance. 7-8 February 2017 Zagreb, Croatia

EIP-AGRI Workshop Tools for environmental farm performance. 7-8 February 2017 Zagreb, Croatia EIP-AGRI Workshop Tools for environmental farm performance 7-8 February 2017 Zagreb, Croatia EIP-AGRI Workshop Tools for environmental farm performance Tuesday 7 February 2017, Zagreb - Croatia 12:00 13:00

More information

System Biology and Immune Response

System Biology and Immune Response System Biology and Immune Response Fondation Mérieux Conference Centre Les Pensières Veyrier-du-Lac - France June 21-23, 2010 Steering Committee: Nicolas BURDIN Bruno GUY Michael KATZE Jacques LOUIS Ray

More information

Nordic Flow Cytometry Meeting

Nordic Flow Cytometry Meeting Nordic Flow Cytometry Meeting 30 31 August and 1 September 2017 Copenhagen, Denmark REGISTRATION Registration to the Nordic Flow Cytometry Meeting starts in December 2016 and includes access to all the

More information

WORKSHOP ON LOCAL GOVERNANCE AND POVERTY REDUCTION IN AFRICA. Tunis, Tunisia June

WORKSHOP ON LOCAL GOVERNANCE AND POVERTY REDUCTION IN AFRICA. Tunis, Tunisia June . DAY ONE-TUESDAY JUNE 21 ST 8:00 9:00 Registration 9:00 10:30 Opening Plenary 9:00 9:30 Opening Ceremony: Welcome Speech--Mr. Michael Bauer, Director, Joint African Institute Introductory Remarks---Mr.

More information

International Conference. The Use of Special Investigation Techniques to Combat Terrorism and other Forms of Serious Crime

International Conference. The Use of Special Investigation Techniques to Combat Terrorism and other Forms of Serious Crime Organization for Security and Co-operation in Europe 13 May 2013 International Conference on The Use of Special Investigation Techniques to Combat Terrorism and other Forms of Serious Crime 14 15 May 2013,

More information

Regulatory system strengthening for medical products

Regulatory system strengthening for medical products EXECUTIVE BOARD 134th session 23 January 2014 Agenda item 9.5 Regulatory system strengthening for medical products Draft resolution proposed by Australia, Colombia, Mexico, Nigeria, South Africa, Switzerland

More information

ZIKAVAX PARTNERSHIP. Dr Odile LEROY DCVMN Seoul 26 th September 2017

ZIKAVAX PARTNERSHIP. Dr Odile LEROY DCVMN Seoul 26 th September 2017 ZIKAVAX PARTNERSHIP Dr Odile LEROY DCVMN Seoul 26 th September 2017 1 Product Development Partnership THE EUROPEAN VACCINE INITIATIVE IS A PRODUC T DEVELOPMENT PARTNERSHIP WHICH AIMS TO ACCELERATE THE

More information

Context and objectives of the workshop on platform technologies. 21 July 2016 David Wood and Virginia Benassi

Context and objectives of the workshop on platform technologies. 21 July 2016 David Wood and Virginia Benassi Context and objectives of the workshop on platform technologies 21 July 2016 David Wood and Virginia Benassi 2nd Technical workshop on platform technologies Geneva, Switzerland, 21 July 2016 Platform Technologies

More information

International Expert Workshop

International Expert Workshop International Expert Workshop TEEB Country Studies Learning from Experience and How to Utilize the Results 21 th 25 th May 2013 International Academy for Nature Conservation Isle of Vilm Germany TEEB Country

More information

Molecular Diagnostics

Molecular Diagnostics Molecular Diagnostics Part II: Regulations, Markets & Companies By Prof. K. K. Jain MD, FRACS, FFPM Jain PharmaBiotech Basel, Switzerland May 2018 A Jain PharmaBiotech Report A U T H O R ' S B I O G R

More information

9:15 Keynote: Regulatory Perspective on Prior Knowledge Martijn van der Plas, Medicines Evaluation Board

9:15 Keynote: Regulatory Perspective on Prior Knowledge Martijn van der Plas, Medicines Evaluation Board Tuesday, 27 November 2018 16 Nov 2018 9:00 Welcome: Opening Remarks & Introductions Falk Klar, PDA Europe Michael De Felippis, Eli Lilly,, 9:15 Keynote: Regulatory Perspective on Prior Knowledge Session

More information

Microsoft Dynamics 365 Business Central. Licensing Guide - Simplified. May 2018

Microsoft Dynamics 365 Business Central. Licensing Guide - Simplified. May 2018 Microsoft Dynamics 365 Business Central Licensing Guide - Simplified May 2018 Source: https://mbs.microsoft.com/files/public/365/dynamics365businesscentrallicensingguide.pdf Created by: ABC E BUSINESS

More information

Advanced Monitoring and Evaluation: Integrating Monitoring, Evaluation and Implementation

Advanced Monitoring and Evaluation: Integrating Monitoring, Evaluation and Implementation Advanced Monitoring and Evaluation: Integrating Monitoring, Evaluation and Implementation 3 day training course Accreditation: This 6-credit HEQF (2007) level nine short course covers knowledge of a formal

More information

The European Medical Technology Industry. in figures / 2018

The European Medical Technology Industry. in figures / 2018 The European Medical Technology Industry in figures / 2018 Table of contents What is Medical Technology? 4 Innovation 10 Employment 14 Companies 18 Expenditure on Medical Technology 20 MedTech Market in

More information

Wadden Sea Board. WSB December 2013 Tønder

Wadden Sea Board. WSB December 2013 Tønder Agenda Item: 8.1 Wadden Sea Board WSB 10 11-12 December 2013 Tønder Subject: Programme Conference Document No. WSB 10/8.1/1 Date: 6 December 2013 Submitted by: DK Attached is the second draft of the programme

More information

INVITATION. Berne, 18. January 2007

INVITATION. Berne, 18. January 2007 Federal Department of Defence, Civil Protection and Sport DDPS armasuisse Real Estate INVITATION Workshop for sustainable building for military infrastructure, Thun, 19-21 September 2007 NATO SPSC, Science

More information

Gasification of Biomass and Waste Recent Activities and Results of IEA Bioenergy Task 33

Gasification of Biomass and Waste Recent Activities and Results of IEA Bioenergy Task 33 Gasification of Biomass and Waste Recent Activities and Results of IEA Bioenergy Task 33 Presentation made by: Berend Vreugdenhil (ECN, Netherlands) Presented by: Timo Gerlagh (RVO.nl, Netherlands) Beijing,

More information

Home truths... the clinical use of components in the UK. Jonathan Wallis. Platelets, FFP, Cryoprecipitate

Home truths... the clinical use of components in the UK. Jonathan Wallis. Platelets, FFP, Cryoprecipitate Home truths... the clinical use of components in the UK Platelets, FFP, Cryoprecipitate Jonathan Wallis Mar-01 Mar-02 Mar-03 Mar-04 Mar-05 Mar-06 Mar-07 Mar-08 Mar-09 Mar-10 Mar-11 Mar-12 E&N.Wales Platelet

More information

WHO Blood Regulators Network (BRN)

WHO Blood Regulators Network (BRN) Distribution: General English only WHO Blood Regulators Network (BRN) Position Paper on Use of Convalescent Plasma, Serum or Immune Globulin Concentrates as an Element in Response to an Emerging Virus*

More information

Cellular Therapy Products & NDC vs. ISBT128 Coding/Labeling

Cellular Therapy Products & NDC vs. ISBT128 Coding/Labeling Cellular Therapy Products & NDC vs. ISBT128 Coding/Labeling William E. Janssen, Ph.D. Director, Cell Therapies Facility Moffitt Cancer Center Tampa, Florida What is ISBT 128? Information standard for blood,

More information

CURRENT COURSE OFFERINGS

CURRENT COURSE OFFERINGS The American Red Cross offers regular educational opportunities as a convenient way for healthcare providers to receive relevant blood banking and transfusion medicine information. The bi-monthly sessions,

More information

CBER Regulatory Updates: Initiatives for Product Review and Licensure

CBER Regulatory Updates: Initiatives for Product Review and Licensure CBER Regulatory Updates: Initiatives for Product Review and Licensure CASSS CMC Strategy Forum Japan 2018 December 3, 2018 Robin Levis, Ph.D. Division of Viral Products Office of Vaccines Research and

More information

English and Communication Skills for European Supervisors

English and Communication Skills for European Supervisors The EUROPEAN SUPERVISOR EDUCATION INITIATIVE (ESE) presents the seminar on English and Communication Skills for European Supervisors hosted by: Banque Centrale du Luxemburg Date: 16 18 May 2018 Venue:

More information

The USERN 2018 Congress and Prize Awarding Festival + Post PID Course

The USERN 2018 Congress and Prize Awarding Festival + Post PID Course The USERN 2018 Congress and Prize Awarding Festival + Post PID Course Day 1: Saturday, November 10, 2018 9:00 11:00 Visit to the Archeological Museum of Magna Graecia and Bronzi di Riace 10:00 11:00 Registration

More information

COUNCIL OF EUROPE CO-OPERATION PROGRAMME TO STRENGTHEN THE RULE OF LAW

COUNCIL OF EUROPE CO-OPERATION PROGRAMME TO STRENGTHEN THE RULE OF LAW CONCL/RES/LISB/BU (2005)1 Ankara, 9 September 2005 COUNCIL OF EUROPE CO-OPERATION PROGRAMME TO STRENGTHEN THE RULE OF LAW Second meeting of the Bureau of the European Network for the exchange of information

More information

AGENDA LEADERSHIP COURSE ON COMMUNICATION AND GOOD CORPORATE GOVERNANCE IN BANKS 9 14 OCTOBER, 2016 DILIJAN, ARMENIA. Program sponsored by:

AGENDA LEADERSHIP COURSE ON COMMUNICATION AND GOOD CORPORATE GOVERNANCE IN BANKS 9 14 OCTOBER, 2016 DILIJAN, ARMENIA. Program sponsored by: AGENDA LEADERSHIP COURSE ON COMMUNICATION AND GOOD CORPORATE GOVERNANCE IN BANKS 9 14 OCTOBER, 2016 DILIJAN, ARMENIA Program sponsored by: Leadership Course on Communication and Good Corporate Governance

More information

A Gateway for Health: BBMRI and Africa Prof. Jan-Eric Litton Director General BBMRI-ERIC

A Gateway for Health: BBMRI and Africa Prof. Jan-Eric Litton Director General BBMRI-ERIC A Gateway for Health: BBMRI and Africa Prof. Jan-Eric Litton Director General Most of our current knowledge on diseases as well as available diagnostic assays and drugs are based on investigation of biological

More information

Welcome & Opening. Ulrike Kreysa, GS1 Global Office Bethesda, MD, 6 April 2011

Welcome & Opening. Ulrike Kreysa, GS1 Global Office Bethesda, MD, 6 April 2011 Welcome & Opening Ulrike Kreysa, GS1 Global Office Bethesda, MD, 6 April 2011 2 GS1 Antitrust Caution Many of the user companies of the GS1 System compete with each other. The competition is both horizontal

More information

Technical Conference on Future Challenges and Opportunities in Agricultural Meteorology. Programme

Technical Conference on Future Challenges and Opportunities in Agricultural Meteorology. Programme Technical Conference on Future Challenges and Opportunities in Agricultural Meteorology Incheon, Republic of Korea 16 to 17 April 2018 Programme 08:00-09:00 hrs Registration SESSION 1: OPENING OF THE WORKSHOP

More information

OECD Workshop Indicators of local transition to a low-carbon economy In Benelux

OECD Workshop Indicators of local transition to a low-carbon economy In Benelux OECD Workshop Indicators of local transition to a low-carbon economy In Benelux Ghent - Belgium Conference Center Novotel Gent Centrum, 11 th June 2012 Agenda Organised by Hosted in Ghent Region by Euregio

More information

EBOLA - HANDS ON WORKSHOP

EBOLA - HANDS ON WORKSHOP ICPIC Pre-meeting workshop June 16, 2015 (10:00-16:50) EBOLA - HANDS ON WORKSHOP 10:00-12:45 Field experiences with Ebola virus disease in West Africa Moderators: Prof. Benedetta Allegranzi, Prof. Babacar

More information

The Integrity of Corporate Registers

The Integrity of Corporate Registers Corporate Registers Forum Annual Conference 2010 The Integrity of Corporate Registers Programme Venue : Conference Centre Sugar Beach Hotel Wolmar, Flic en Flac Mauritius Duration : Monday 19 to Friday

More information

Supporting Decentralisation in Ukraine:

Supporting Decentralisation in Ukraine: AGENDA Supporting Decentralisation in Ukraine: Enhancing local civil service performance for effective public service delivery Friday 2 March 2018 10:00 18:00 Intercontinental Hotel Kyiv 2A Velyka Zhytomyrska

More information

Patient Involvement in HTA: An example of How and Why. 26 September 2017

Patient Involvement in HTA: An example of How and Why. 26 September 2017 Patient Involvement in HTA: An example of How and Why 26 September 2017 Background A pharma company launching a new drug commissioned an HTA evaluation to an Academic Institution in Italy Patient Experts

More information

EUROPEAN COMMISSION HEALTH AND CONSUMERS DIRECTORATE-GENERAL. PHARMACEUTICAL COMMITTEE 22 October 2012

EUROPEAN COMMISSION HEALTH AND CONSUMERS DIRECTORATE-GENERAL. PHARMACEUTICAL COMMITTEE 22 October 2012 EUROPEAN COMMISSION HEALTH AND CONSUMERS DIRECTORATE-GENERAL Health systems and products Medicinal products authorisations, EMA PHARM 608 PHARMACEUTICAL COMMITTEE 22 October 2012 Subject: Hospital exemption

More information

NMI Natural and Medical Sciences Institute at the University of Tübingen

NMI Natural and Medical Sciences Institute at the University of Tübingen NMI Natural and Medical Sciences Institute at the University of Tübingen Markwiesenstrasse 55, 72770 Reutlingen, Germany GPS-Coordinate: 48 29 38.24 N 9 08 02.73 O AGENDA Get updated about latest developments

More information

4 th ESPT SUMMER SCHOOL

4 th ESPT SUMMER SCHOOL 4 th ESPT SUMMER SCHOOL PRECISION MEDICINE AND PERSONALISED HEALTH September 24-27, 2018 Geneva, Switzerland Dear Colleagues and Friends, It is a great pleasure and honour to invite you to the 4th ESPT

More information

Credit Guarantee Schemes: Regulation and Management

Credit Guarantee Schemes: Regulation and Management PUTTING IN PLACE THE CONDITIONS TO SET UP A CREDIT GUARANTEE SCHEME FOR AGRIBUSINESS SMEs IN UKRAINE Credit Guarantee Schemes: Regulation and Management Capacity Building Seminars 22-24 February 2016 Ministry

More information

EXPERT COMMITTEE ON BIOLOGICAL STANDARDIZATION Geneva, 21 to 25 October 2013

EXPERT COMMITTEE ON BIOLOGICAL STANDARDIZATION Geneva, 21 to 25 October 2013 EXPERT COMMITTEE ON BIOLOGICAL STANDARDIZATION Geneva, 21 to 25 October 2013 ENGLISH ONLY Collaborative Study to Evaluate the Proposed 3 rd WHO International Standard for Parvovirus B19 (B19V) for Nucleic

More information

Schedule. Day 1. 29/1/ Monday. Time Topic Speaker 9:00-9:30 AM Inaugural Event - Welcome and Lighting

Schedule. Day 1. 29/1/ Monday. Time Topic Speaker 9:00-9:30 AM Inaugural Event - Welcome and Lighting Date Time Event JSS & UMC staff will meet the participants at Hotel Dawn 28/1/2018 6:00 PM Welcome Dinner at Hotel Royal Orchid Metropole Sunday 10:00 PM Participants interview each other by using Agile

More information

PROGRAMME T

PROGRAMME T BIOART Summer School Biomedical membranes and (bio)artificial organs 8-12 June 2015 Venue University of Twente Horstring Building Room N 109 PROGRAMME Contents Welcome to the BIOART Summer School-------------------------------

More information

Best Practices for the Use of International Standards in Vaccine Testing Dianna Wilkinson

Best Practices for the Use of International Standards in Vaccine Testing Dianna Wilkinson Best Practices for the Use of International Standards in Vaccine Testing Dianna Wilkinson DCVMN Regional Training Workshop Hyderabad, 07-10 May, 2018 Biologicals substances which cannot be fully characterized

More information

PRELIMINARY SCIENTIFIC PROGRAM (June 14, 2017) (TBC: To Be Confirmed) Sunday 30, September WELCOME RECEPTION. Monday 1st, October 09:00 am to 02:00 pm

PRELIMINARY SCIENTIFIC PROGRAM (June 14, 2017) (TBC: To Be Confirmed) Sunday 30, September WELCOME RECEPTION. Monday 1st, October 09:00 am to 02:00 pm PRELIMINARY SCIENTIFIC PROGRAM (June 14, 2017) (TBC: To Be Confirmed) Sunday 30, September 04:00 pm 06:00 pm REGISTRATION 06:00 pm 06:15 pm - WELCOME - Sofia Siest, Nancy, France 06:15 pm 07:15 pm - KEYNOTE

More information

Dennis Williams, MD Kentucky Blood Center University of Kentucky Dept. Path and Lab Med

Dennis Williams, MD Kentucky Blood Center University of Kentucky Dept. Path and Lab Med Dennis Williams, MD Kentucky Blood Center University of Kentucky Dept. Path and Lab Med None Disclosures Objectives 1) Describe the FDA Draft Guidance Background and Requirements 2) Review the responsibilities

More information

FDA Perspective on Plasma Quality and GMPs

FDA Perspective on Plasma Quality and GMPs FDA Perspective on Plasma Quality and GMPs Judy Ellen Ciaraldi Food and Drug Administration Division of Blood Components & Devices/OBRR/CBER IPFA/BCA Global Symposium September 23, 2014 Sacramento, California

More information

Biobanking and Biomolecular Resources Research Infrastructure: The need for common standards

Biobanking and Biomolecular Resources Research Infrastructure: The need for common standards Biobanking and Biomolecular Resources Research Infrastructure: The need for common standards K. Zatloukal Medical University of Graz, Austria Washington, Embassy of Austria June 5th 2012 Biobanks and Biomolecular

More information

TASK FORCE ON INTEGRATED ASSESSMENT MODELLING (TFIAM) 42 nd session, April 2013 Copenhagen, Denmark. Draft Chairs report I.

TASK FORCE ON INTEGRATED ASSESSMENT MODELLING (TFIAM) 42 nd session, April 2013 Copenhagen, Denmark. Draft Chairs report I. TASK FORCE ON INTEGRATED ASSESSMENT MODELLING (TFIAM) 42 nd session, 22-23 April 2013 Copenhagen, Denmark Draft Chairs report I. INTRODUCTION 1. This report describes the results of the 42 nd session of

More information

4 th ESPT SUMMER SCHOOL

4 th ESPT SUMMER SCHOOL 4 th ESPT SUMMER SCHOOL SUPPORTED BY SPHN PRECISION MEDICINE AND PERSONALISED HEALTH September 24-27, 2018 Geneva, Switzerland Dear Colleagues and Friends, It is a great pleasure and honour to invite you

More information

ReSPA Summer School on Accession Negotiations with the European Union Chapters 23 and 24

ReSPA Summer School on Accession Negotiations with the European Union Chapters 23 and 24 ReSPA Summer School on Accession Negotiations with the European Union Chapters 23 and 24 08.45 09.00 Registration of participants 09.00 09.30 Welcome and Introduction ReSPA, Danilovgrad, 3-7 July 2017

More information

Key findings. Objectives

Key findings. Objectives Key findings Creative Ceutical Report An EU-wide overview of the market of blood, blood components and plasma derivatives focusing on their availability for patients Objectives The purpose of this Creative

More information

WHY UNITAID MATTERS FOR PEOPLE LIVING WITH HIV/AIDS, TB AND MALARIA MARKET IMPACT

WHY UNITAID MATTERS FOR PEOPLE LIVING WITH HIV/AIDS, TB AND MALARIA MARKET IMPACT WHY UNITAID MATTERS FOR PEOPLE LIVING WITH HIV/AIDS, TB AND MALARIA MARKET IMPACT by the Civil Society Delegations to UNITAID PROBLEM SOLUTION MARKET JOURNEY GOAL 1 No appropriate product Product adapted

More information

Schedule, part II of the training programme: Sustainable Urban Water and Sanitation Integrated Processes Lund University, 28 March 15 April, 2011.

Schedule, part II of the training programme: Sustainable Urban Water and Sanitation Integrated Processes Lund University, 28 March 15 April, 2011. Schedule, part II of the training programme: Sustainable Urban Water and Sanitation Integrated Processes Lund University, 28 March 15 April, 2011. : Lars Bengtsson (), Peder Hjorth (PH), Berndtsson (JCB),

More information